SCHEMBL4606789

SCHEMBL4606789

[CH2]C1Cc2cc(F)cc(-c3cc(Cl)ccc3OC)c2O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.47
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ALDH1A1 P00352 5/20 0.36
HPGD P15428 4/20 0.36
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
KDM4E B2RXH2 2/20 0.35
CETP P11597 1/20 0.35
USP2 O75604 1/20 0.35
PRNP P04156 1/20 0.35
PPARG P37231 1/20 0.35
MAPK10 P53779 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597088 0.90 HTR2A (0.47) AQP1HTR2AHTR2CALDH1A1HPGD
SCHEMBL4713088 0.87 HTR2C (0.40) AQP1HTR2AHTR2CALDH1A1HPGD
SCHEMBL4606791 0.87 AQP1 (0.47) AQP1HTR2AHTR2CALDH1A1HPGD
SCHEMBL4595096 0.87 AQP1 (0.35) AQP1HTR2AHTR2CALDH1A1CETP
SCHEMBL4714768 0.87 MAOB (0.36) AQP1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL4596825 0.84 AQP1 (0.52) AQP1CETP
SCHEMBL4596598 0.84 HTR7 (0.37) AQP1HTR2AHTR2CRAB9A
SCHEMBL4713099 0.84 AQP1 (0.54) AQP1HTR2AHTR2C
SCHEMBL4596119 0.83 HTR2A (0.41) HTR2AHTR2CALDH1A1HPGDHTR3E
SCHEMBL4764341 0.81 AQP1 (0.55) AQP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
EP-1871355-A1 NEW THERAPEUTIC COMBIANATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION Wyeth (US) 2008-01-02 EP disclosed
WO-2006116149-A1 NEW THERAPEUTIC COMBIANATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION WYETH (US) 2006-11-02 WO disclosed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP disclosed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO disclosed